- call +1-201-465-4211
- email sales@mrinsights.biz
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
Scope of the Report:
This report focuses on the Sodium Valproate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Sodium Valproate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
sanofi-aventis
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Injection
Tablet
Liquid
Market Segment by Applications, can be divided into
Epilepsy
Migraines
Others
There are 15 Chapters to deeply display the global Sodium Valproate market.
Chapter 1, to describe Sodium Valproate Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Sodium Valproate, with sales, revenue, and price of Sodium Valproate, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Sodium Valproate, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Sodium Valproate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Sodium Valproate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Sodium Valproate Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Tablet
1.2.3 Liquid
1.3 Market Analysis by Applications
1.3.1 Epilepsy
1.3.2 Migraines
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 sanofi-aventis
2.1.1 Business Overview
2.1.1.1 sanofi-aventis Description
2.1.1.2 sanofi-aventis Headquarter, Main Business and Finance Overview
2.1.2 sanofi-aventis Sodium Valproate Product Introduction
2.1.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.1.2.2 Sodium Valproate Product Information
2.1.3 sanofi-aventis Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 sanofi-aventis Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global sanofi-aventis Sodium Valproate Market Share in 2017
2.2 AbbVie
2.2.1 Business Overview
2.2.1.1 AbbVie Description
2.2.1.2 AbbVie Headquarter, Main Business and Finance Overview
2.2.2 AbbVie Sodium Valproate Product Introduction
2.2.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.2.2.2 Sodium Valproate Product Information
2.2.3 AbbVie Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 AbbVie Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global AbbVie Sodium Valproate Market Share in 2017
2.3 Athenex
2.3.1 Business Overview
2.3.1.1 Athenex Description
2.3.1.2 Athenex Headquarter, Main Business and Finance Overview
2.3.2 Athenex Sodium Valproate Product Introduction
2.3.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.3.2.2 Sodium Valproate Product Information
2.3.3 Athenex Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Athenex Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Athenex Sodium Valproate Market Share in 2017
2.4 Fresenius Kabi
2.4.1 Business Overview
2.4.1.1 Fresenius Kabi Description
2.4.1.2 Fresenius Kabi Headquarter, Main Business and Finance Overview
2.4.2 Fresenius Kabi Sodium Valproate Product Introduction
2.4.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.4.2.2 Sodium Valproate Product Information
2.4.3 Fresenius Kabi Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Fresenius Kabi Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Fresenius Kabi Sodium Valproate Market Share in 2017
2.5 Hikma Farmaceutica
2.5.1 Business Overview
2.5.1.1 Hikma Farmaceutica Description
2.5.1.2 Hikma Farmaceutica Headquarter, Main Business and Finance Overview
2.5.2 Hikma Farmaceutica Sodium Valproate Product Introduction
2.5.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.5.2.2 Sodium Valproate Product Information
2.5.3 Hikma Farmaceutica Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Hikma Farmaceutica Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Hikma Farmaceutica Sodium Valproate Market Share in 2017
2.6 Desitin Pharmaceuticals
2.6.1 Business Overview
2.6.1.1 Desitin Pharmaceuticals Description
2.6.1.2 Desitin Pharmaceuticals Headquarter, Main Business and Finance Overview
2.6.2 Desitin Pharmaceuticals Sodium Valproate Product Introduction
2.6.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.6.2.2 Sodium Valproate Product Information
2.6.3 Desitin Pharmaceuticals Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Desitin Pharmaceuticals Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Desitin Pharmaceuticals Sodium Valproate Market Share in 2017
2.7 Wockhardt
2.7.1 Business Overview
2.7.1.1 Wockhardt Description
2.7.1.2 Wockhardt Headquarter, Main Business and Finance Overview
2.7.2 Wockhardt Sodium Valproate Product Introduction
2.7.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.7.2.2 Sodium Valproate Product Information
2.7.3 Wockhardt Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Wockhardt Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Wockhardt Sodium Valproate Market Share in 2017
2.8 Zentiva
2.8.1 Business Overview
2.8.1.1 Zentiva Description
2.8.1.2 Zentiva Headquarter, Main Business and Finance Overview
2.8.2 Zentiva Sodium Valproate Product Introduction
2.8.2.1 Sodium Valproate Production Bases, Sales Regions and Major Competitors
2.8.2.2 Sodium Valproate Product Information
2.8.3 Zentiva Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Zentiva Sodium Valproate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Zentiva Sodium Valproate Market Share in 2017
3 Global Sodium Valproate Market Competition, by Manufacturer
3.1 Global Sodium Valproate Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Sodium Valproate Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Sodium Valproate Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Sodium Valproate Manufacturer Market Share in 2017
3.4.2 Top 5 Sodium Valproate Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Sodium Valproate Market Analysis by Regions
4.1 Global Sodium Valproate Sales, Revenue and Market Share by Regions
4.1.1 Global Sodium Valproate Sales by Regions (2013-2018)
4.1.2 Global Sodium Valproate Revenue by Regions (2013-2018)
4.2 North America Sodium Valproate Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Sodium Valproate Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Sodium Valproate Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Sodium Valproate Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Sodium Valproate Sales, Revenue and Growth Rate (2013-2018)
5 North America Sodium Valproate by Countries, Type, Application and Manufacturers
5.1 North America Sodium Valproate Sales, Revenue and Market Share by Countries
5.1.1 North America Sodium Valproate Sales by Countries (2013-2018)
5.1.2 North America Sodium Valproate Revenue by Countries (2013-2018)
5.1.3 United States Sodium Valproate Sales and Growth Rate (2013-2018)
5.1.4 Canada Sodium Valproate Sales and Growth Rate (2013-2018)
5.1.5 Mexico Sodium Valproate Sales and Growth Rate (2013-2018)
5.2 North America Sodium Valproate Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Sodium Valproate Sales by Manufacturers (2016-2017)
5.2.2 North America Sodium Valproate Revenue by Manufacturers (2016-2017)
5.3 North America Sodium Valproate Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Sodium Valproate Sales and Sales Share by Type (2013-2018)
5.3.2 North America Sodium Valproate Revenue and Revenue Share by Type (2013-2018)
5.4 North America Sodium Valproate Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Sodium Valproate Sales and Sales Share by Application (2013-2018)
5.4.2 North America Sodium Valproate Revenue and Revenue Share by Application (2013-2018)
6 Europe Sodium Valproate by Countries, Type, Application and Manufacturers
6.1 Europe Sodium Valproate Sales, Revenue and Market Share by Countries
6.1.1 Europe Sodium Valproate Sales by Countries (2013-2018)
6.1.2 Europe Sodium Valproate Revenue by Countries (2013-2018)
6.1.3 Germany Sodium Valproate Sales and Growth Rate (2013-2018)
6.1.4 UK Sodium Valproate Sales and Growth Rate (2013-2018)
6.1.5 France Sodium Valproate Sales and Growth Rate (2013-2018)
6.1.6 Russia Sodium Valproate Sales and Growth Rate (2013-2018)
6.1.7 Italy Sodium Valproate Sales and Growth Rate (2013-2018)
6.2 Europe Sodium Valproate Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Sodium Valproate Sales by Manufacturers (2016-2017)
6.2.2 Europe Sodium Valproate Revenue by Manufacturers (2016-2017)
6.3 Europe Sodium Valproate Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Sodium Valproate Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Sodium Valproate Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Sodium Valproate Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Sodium Valproate Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Sodium Valproate Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Sodium Valproate by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Sodium Valproate Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Sodium Valproate Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Sodium Valproate Revenue by Countries (2013-2018)
7.1.3 China Sodium Valproate Sales and Growth Rate (2013-2018)
7.1.4 Japan Sodium Valproate Sales and Growth Rate (2013-2018)
7.1.5 Korea Sodium Valproate Sales and Growth Rate (2013-2018)
7.1.6 India Sodium Valproate Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Sodium Valproate Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Sodium Valproate Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Sodium Valproate Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Sodium Valproate Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Sodium Valproate Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Sodium Valproate Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Sodium Valproate Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Sodium Valproate Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Sodium Valproate Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Sodium Valproate Revenue and Revenue Share by Application (2013-2018)
8 South America Sodium Valproate by Countries, Type, Application and Manufacturers
8.1 South America Sodium Valproate Sales, Revenue and Market Share by Countries
8.1.1 South America Sodium Valproate Sales by Countries (2013-2018)
8.1.2 South America Sodium Valproate Revenue by Countries (2013-2018)
8.1.3 Brazil Sodium Valproate Sales and Growth Rate (2013-2018)
8.1.4 Argentina Sodium Valproate Sales and Growth Rate (2013-2018)
8.1.5 Colombia Sodium Valproate Sales and Growth Rate (2013-2018)
8.2 South America Sodium Valproate Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Sodium Valproate Sales by Manufacturers (2016-2017)
8.2.2 South America Sodium Valproate Revenue by Manufacturers (2016-2017)
8.3 South America Sodium Valproate Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Sodium Valproate Sales and Sales Share by Type (2013-2018)
8.3.2 South America Sodium Valproate Revenue and Revenue Share by Type (2013-2018)
8.4 South America Sodium Valproate Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Sodium Valproate Sales and Sales Share by Application (2013-2018)
8.4.2 South America Sodium Valproate Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Sodium Valproate by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Sodium Valproate Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Sodium Valproate Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Sodium Valproate Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Sodium Valproate Sales and Growth Rate (2013-2018)
9.1.4 UAE Sodium Valproate Sales and Growth Rate (2013-2018)
9.1.5 Egypt Sodium Valproate Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Sodium Valproate Sales and Growth Rate (2013-2018)
9.1.7 South Africa Sodium Valproate Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Sodium Valproate Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Sodium Valproate Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Sodium Valproate Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Sodium Valproate Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Sodium Valproate Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Sodium Valproate Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Sodium Valproate Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Sodium Valproate Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Sodium Valproate Revenue and Revenue Share by Application (2013-2018)
10 Global Sodium Valproate Market Segment by Type
10.1 Global Sodium Valproate Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Sodium Valproate Sales and Market Share by Type (2013-2018)
10.1.2 Global Sodium Valproate Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2013-2018)
10.2.2 Global Injection Price (2013-2018)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2013-2018)
10.3.2 Global Tablet Price (2013-2018)
10.4 Liquid Sales Growth and Price
10.4.1 Global Liquid Sales Growth (2013-2018)
10.4.2 Global Liquid Price (2013-2018)
11 Global Sodium Valproate Market Segment by Application
11.1 Global Sodium Valproate Sales Market Share by Application (2013-2018)
11.2 Epilepsy Sales Growth (2013-2018)
11.3 Migraines Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Sodium Valproate Market Forecast (2018-2023)
12.1 Global Sodium Valproate Sales, Revenue and Growth Rate (2018-2023)
12.2 Sodium Valproate Market Forecast by Regions (2018-2023)
12.2.1 North America Sodium Valproate Market Forecast (2018-2023)
12.2.2 Europe Sodium Valproate Market Forecast (2018-2023)
12.2.3 Asia-Pacific Sodium Valproate Market Forecast (2018-2023)
12.2.4 South America Sodium Valproate Market Forecast (2018-2023)
12.2.5 Middle East and Africa Sodium Valproate Market Forecast (2018-2023)
12.3 Sodium Valproate Market Forecast by Type (2018-2023)
12.3.1 Global Sodium Valproate Sales Forecast by Type (2018-2023)
12.3.2 Global Sodium Valproate Market Share Forecast by Type (2018-2023)
12.4 Sodium Valproate Market Forecast by Application (2018-2023)
12.4.1 Global Sodium Valproate Sales Forecast by Application (2018-2023)
12.4.2 Global Sodium Valproate Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Sodium Valproate Picture
Table Product Specifications of Sodium Valproate
Figure Global Sodium Valproate CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
